Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Common Stock | Options Exercise | $85.8K | +1.67K | +44.41% | $51.50 | 5.42K | Oct 27, 2021 | Direct | F1 |
transaction | TNDM | Common Stock | Options Exercise | $19.6K | +238 | +4.39% | $82.34 | 5.66K | Oct 27, 2021 | Direct | F1 |
transaction | TNDM | Common Stock | Sale | -$248K | -1.9K | -33.67% | $130.34 | 3.75K | Oct 27, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Stock Option | Options Exercise | -$85.8K | -1.67K | -5.88% | $51.50 | 26.7K | Oct 27, 2021 | Common Stock | 1.67K | $51.50 | Direct | F3, F4 |
transaction | TNDM | Stock Option | Options Exercise | -$19.6K | -238 | -3.12% | $82.34 | 7.39K | Oct 27, 2021 | Common Stock | 238 | $82.34 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Represents shares of common stock received upon exercise of a stock option award. |
F2 | The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. |
F3 | The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). |
F4 | The expiration date for these options is 10 years from the date of grant. |
F5 | The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. |